Cardinal Health, Inc.
CAH · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $64,009 | $60,159 | $54,878 | $55,264 |
| % Growth | 6.4% | 9.6% | -0.7% | – |
| Cost of Goods Sold | $61,690 | $57,957 | $52,755 | $53,323 |
| Gross Profit | $2,319 | $2,202 | $2,123 | $1,941 |
| % Margin | 3.6% | 3.7% | 3.9% | 3.5% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1,461 | $1,484 | $1,315 | $1,306 |
| Sales & Mktg Exp. | $1,461 | $1,484 | $1,315 | $1,306 |
| Other Operating Expenses | $190 | $290 | $78 | $86 |
| Operating Expenses | $1,651 | $1,774 | $1,393 | $1,392 |
| Operating Income | $668 | $428 | $730 | $549 |
| % Margin | 1% | 0.7% | 1.3% | 1% |
| Other Income/Exp. Net | -$70 | -$44 | -$65 | -$38 |
| Pre-Tax Income | $598 | $384 | $665 | $511 |
| Tax Expense | $144 | $141 | $157 | $110 |
| Net Income | $450 | $239 | $506 | $400 |
| % Margin | 0.7% | 0.4% | 0.9% | 0.7% |
| EPS | 1.89 | 1 | 2.11 | 1.65 |
| % Growth | 89% | -52.6% | 27.9% | – |
| EPS Diluted | 1.88 | 1 | 2.1 | 1.65 |
| Weighted Avg Shares Out | 238 | 239 | 240 | 242 |
| Weighted Avg Shares Out Dil | 239 | 240 | 241 | 243 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $80 | $74 | $74 | $35 |
| Depreciation & Amortization | $233 | $209 | $207 | $192 |
| EBITDA | $911 | $667 | $946 | $738 |
| % Margin | 1.4% | 1.1% | 1.7% | 1.3% |